228 related articles for article (PubMed ID: 37540514)
21. Distribution of take-home opioid antagonist kits during a synthetic opioid epidemic in British Columbia, Canada: a modelling study.
Irvine MA; Buxton JA; Otterstatter M; Balshaw R; Gustafson R; Tyndall M; Kendall P; Kerr T; Gilbert M; Coombs D
Lancet Public Health; 2018 May; 3(5):e218-e225. PubMed ID: 29678561
[TBL] [Abstract][Full Text] [Related]
22. Polysubstance use in rural West Virginia: Associations between latent classes of drug use, overdose, and take-home naloxone.
Schneider KE; O'Rourke A; White RH; Park JN; Musci RJ; Kilkenny ME; Sherman SG; Allen ST
Int J Drug Policy; 2020 Feb; 76():102642. PubMed ID: 31918401
[TBL] [Abstract][Full Text] [Related]
23. Exploring the life-saving potential of naloxone: A systematic review and descriptive meta-analysis of take home naloxone (THN) programmes for opioid users.
McAuley A; Aucott L; Matheson C
Int J Drug Policy; 2015 Dec; 26(12):1183-8. PubMed ID: 26508033
[TBL] [Abstract][Full Text] [Related]
24. Take-home naloxone programs for suspected opioid overdose in community settings: a scoping umbrella review.
Moustaqim-Barrette A; Dhillon D; Ng J; Sundvick K; Ali F; Elton-Marshall T; Leece P; Rittenbach K; Ferguson M; Buxton JA
BMC Public Health; 2021 Mar; 21(1):597. PubMed ID: 33771150
[TBL] [Abstract][Full Text] [Related]
25. Training family members to manage heroin overdose and administer naloxone: randomized trial of effects on knowledge and attitudes.
Williams AV; Marsden J; Strang J
Addiction; 2014 Feb; 109(2):250-9. PubMed ID: 24103087
[TBL] [Abstract][Full Text] [Related]
26. Take-Home Naloxone Kits: Attitudes and Likelihood-Of-Use Outcomes from a European Survey of Potential Overdose Witnesses.
McDonald R; Breidahl S; Abel-Ollo K; Akhtar S; Clausen T; Day E; Kelleher M; McAuley A; Petersen H; Sefranek M; Thiesen H; Strang J
Eur Addict Res; 2022; 28(3):220-225. PubMed ID: 35114666
[TBL] [Abstract][Full Text] [Related]
27. Twenty years of take-home naloxone for the prevention of overdose deaths from heroin and other opioids-Conception and maturation.
McDonald R; Campbell ND; Strang J
Drug Alcohol Depend; 2017 Sep; 178():176-187. PubMed ID: 28654870
[TBL] [Abstract][Full Text] [Related]
28. A systematic review and meta-analysis of the prevalence of take-home naloxone (THN) ownership and carriage.
Burton G; McAuley A; Schofield J; Yeung A; Matheson C; Parkes T
Int J Drug Policy; 2021 Oct; 96():103298. PubMed ID: 34078563
[TBL] [Abstract][Full Text] [Related]
29. An overview of take-home naloxone programs in Australia.
Dwyer R; Olsen A; Fowlie C; Gough C; van Beek I; Jauncey M; Lintzeris N; Oh G; Dicka J; Fry CL; Hayllar J; Lenton S
Drug Alcohol Rev; 2018 May; 37(4):440-449. PubMed ID: 29744980
[TBL] [Abstract][Full Text] [Related]
30. Does training people to administer take-home naloxone increase their knowledge? Evidence from Australian programs.
Dietze PM; Draper B; Olsen A; Chronister KJ; van Beek I; Lintzeris N; Dwyer R; Nelson M; Lenton S
Drug Alcohol Rev; 2018 May; 37(4):472-479. PubMed ID: 29473245
[TBL] [Abstract][Full Text] [Related]
31. Remaking the 'angry Narcanned subject': Affording new subject positions through take-home naloxone training.
Ferguson N; Farrugia A; Moore D; Fraser S
Int J Drug Policy; 2024 Jan; 123():104253. PubMed ID: 37995551
[TBL] [Abstract][Full Text] [Related]
32. A study protocol for a European, mixed methods, prospective, cohort study of the effectiveness of naloxone administration by community members, in reversing opioid overdose: NalPORS.
Metrebian N; Carter B; Eide D; McDonald R; Neale J; Parkin S; Dascal T; Mackie C; Day E; Guterstam J; Horsburgh K; Kåberg M; Kelleher M; Smith J; Thiesen H; Strang J
BMC Public Health; 2023 Aug; 23(1):1608. PubMed ID: 37612698
[TBL] [Abstract][Full Text] [Related]
33. More than saving lives: Qualitative findings of the UNODC/WHO Stop Overdose Safely (S-O-S) project.
Walker S; Dietze P; Poznyak V; Campello G; Kashino W; Dzhonbekov D; Kiriazova T; Nikitin D; Terlikbayeva A; Nevendorff L; Busse A; Krupchanka D
Int J Drug Policy; 2022 Feb; 100():103482. PubMed ID: 35042142
[TBL] [Abstract][Full Text] [Related]
34. Accessing Take-Home Naloxone in British Columbia and the role of community pharmacies: Results from the analysis of administrative data.
Moustaqim-Barrette A; Papamihali K; Mamdani Z; Williams S; Buxton JA
PLoS One; 2020; 15(9):e0238618. PubMed ID: 32915834
[TBL] [Abstract][Full Text] [Related]
35. The extent of and factors associated with self-reported overdose and self-reported receipt of naloxone among people who inject drugs (PWID) in England, Wales and Northern Ireland.
O'Halloran C; Cullen K; Njoroge J; Jessop L; Smith J; Hope V; Ncube F
Int J Drug Policy; 2017 Aug; 46():34-40. PubMed ID: 28586701
[TBL] [Abstract][Full Text] [Related]
36. Access and Barriers to Take-Home Naloxone Use among Emergency Department Patients with Opioid Misuse in Baltimore, Maryland, USA.
Hurt BR; Hussain A; Aledhaim A; Moayedi S; Schenkel SM; Kim HK
Subst Use Misuse; 2020; 55(13):2237-2242. PubMed ID: 32729772
[TBL] [Abstract][Full Text] [Related]
37. More than just availability: Who has access and who administers take-home naloxone in Baltimore, MD.
Dayton L; Gicquelais RE; Tobin K; Davey-Rothwell M; Falade-Nwulia O; Kong X; Fingerhood M; Jones AA; Latkin C
PLoS One; 2019; 14(11):e0224686. PubMed ID: 31697736
[TBL] [Abstract][Full Text] [Related]
38. The Overdose Response with Take Home Naloxone (ORTHN) project: Evaluation of health worker training, attitudes and perceptions.
Monds LA; Bravo M; Mills L; Malcolm A; Gilliver R; Wood W; Harrod ME; Read P; Nielsen S; Dietze PM; Lenton S; Bleeker AM; Lintzeris N
Drug Alcohol Rev; 2022 Jul; 41(5):1085-1094. PubMed ID: 35442514
[TBL] [Abstract][Full Text] [Related]
39. Design details for overdose education and take-home naloxone kits: Codesign with family medicine, emergency department, addictions medicine and community.
Sellen K; Goso N; Halleran L; Mulvale-Fletcher A; Sarmiento F; Ligabue F; Handford C; Klaiman M; Milos G; Wright A; Charles M; Sniderman R; Hunt R; Parsons JA; Leece P; Hopkins S; Shahin R; Jüni P; Morrison L; Campbell DM; Strike C; Orkin A;
Health Expect; 2022 Oct; 25(5):2440-2452. PubMed ID: 35909312
[TBL] [Abstract][Full Text] [Related]
40. Knowledge and possession of take-home naloxone kits among street-involved youth in a Canadian setting: a cohort study.
Goldman-Hasbun J; DeBeck K; Buxton JA; Nosova E; Wood E; Kerr T
Harm Reduct J; 2017 Dec; 14(1):79. PubMed ID: 29273031
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
